EAM Global Investors’s Axogen AXGN Stock Holding History

EAM Global Investors’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-31,881	Closed	-$1.6M	–	153
2018 Q2	$1.6M	Sell	31,881 -12,364	-28%	-$545K	0.78%	18
2018 Q1	$1.61M	Sell	44,245 -10,730	-20%	-$329K	0.84%	12
2017 Q4	$1.56M	Buy	+54,975	New	+$1.3M	0.8%	14

Other funds holding AXGN

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EAM Global Investors's AXGN Position: Q3 2018 in Review

EAM Global Investors sold out of Axogen (AXGN) in Q3 2018, closing a stake of 31,881 shares — an estimated $1.6M sold.

EAM Global Investors first reported a position in AXGN in Q4 2017 and held it in 3 quarters. The position peaked at $1.61M in Q1 2018. 162 funds tracked by Wall St. Rank hold AXGN as of Q3 2018.

EAM Global Investors reported no remaining Axogen position as of Q3 2018 after selling out during the quarter.
EAM Global Investors sold 31,881 Axogen shares in Q3 2018, an estimated $1.6M.
EAM Global Investors first reported a position in Axogen in Q4 2017 and held it in 3 quarters.
EAM Global Investors's Axogen position peaked at $1.61M in Q1 2018.
162 funds tracked by Wall St. Rank held Axogen as of Q3 2018.

Based on EAM Global Investors's 13F filing for Q3 2018, filed 8 Nov 2018.